Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$13.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 15 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 40 most recent Form 4 transactions.
| Aug 4 | NBIX | Neurocrine Biosciences INC | GGIFT | 2,409 | — | — | -10.3% | Open the original filing on SEC.gov |
| Jun 9 | VYGR | Voyager Therapeutics, Inc. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | NBIX | Neurocrine Biosciences INC | GGIFT | 2,441 | — | — | -9.4% | Open the original filing on SEC.gov |
| Jun 1 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 11,000 | $160.25 | $1.8M | -29.8% | Open the original filing on SEC.gov |
| Jun 1 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 11,000 | $84.74 | $932.1K | +42.6% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 11,000 | $155.53 | $1.7M | -29.8% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 11,000 | $84.74 | $932.1K | +42.6% | Open the original filing on SEC.gov |
| Feb 20 | NBIX | Neurocrine Biosciences INC | GGIFT | 3,110 | — | — | -10.8% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 9,669 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 55,119 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,717 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,690 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 10,755 | $124.12 | $1.3M | -27.2% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 19,935 | — | — | +101.7% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,466 | $124.12 | $182K | -7.0% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,717 | — | — | +14.8% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,452 | $124.12 | $180.2K | -7.3% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,690 | — | — | +15.7% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,560 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 1,426 | $123.10 | $175.5K | -7.7% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 2,560 | — | — | +16.0% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 238 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 142 | $136.06 | $19.3K | -0.9% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 238 | — | — | +1.5% | Open the original filing on SEC.gov |
| Nov 29, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 4,426 | — | — | — | Open the original filing on SEC.gov |
| Nov 29, 2025 | NBIX | Neurocrine Biosciences INC | FTAX | 2,248 | $152.16 | $342.1K | -12.4% | Open the original filing on SEC.gov |
| Nov 29, 2025 | NBIX | Neurocrine Biosciences INC | MEXER | 4,426 | — | — | +32.3% | Open the original filing on SEC.gov |
| Sep 3, 2025 | NBIX | Neurocrine Biosciences INC | GGIFT | 1,470 | — | — | -9.7% | Open the original filing on SEC.gov |
| Aug 5, 2025 | NBIX | Neurocrine Biosciences INC | GGIFT | 3,116 | — | — | -17.0% | Open the original filing on SEC.gov |
| Jul 9, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 59,819 | — | — | — | Open the original filing on SEC.gov |
| Jul 9, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 59,819 | $130.46 | $7.8M | -76.6% | Open the original filing on SEC.gov |
| Jul 9, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 59,819 | $84.74 | $5.1M | +327.1% | Open the original filing on SEC.gov |
| Jul 2, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 20,362 | — | — | — | Open the original filing on SEC.gov |
| Jul 2, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 20,362 | $130.13 | $2.6M | -52.7% | Open the original filing on SEC.gov |
| Jul 2, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 20,362 | $84.74 | $1.7M | +111.3% | Open the original filing on SEC.gov |
| Jun 3, 2025 | VYGR | Voyager Therapeutics, Inc. | AGRANT◆ | 24,000 | — | — | — | Open the original filing on SEC.gov |